Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation

BACKGROUND: Cilostazol, an anti-platelet drug for treating coronary heart disease, has been reported to modulate immune cell functions. Plasmacytoid dendritic cells (pDCs) have been found to participate in the progression of atherosclerosis mainly through interferon α (IFN-α) production. Whether cil...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Geriatr Cardiol
Autores principales: Sun, Fei, Yin, Zhao, Yu, Hai-Sheng, Shi, Quan-Xing, Zhao, Bei, Zhang, Li-Guo, Wang, Shou-Li
Formato: Artigo
Lenguaje:Inglês
Publicado: Science Press 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554787/
https://ncbi.nlm.nih.gov/pubmed/26345215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares